Factors such as the increasing prevalence of chronic diseases and rising therapeutics demand are estimated to drive the market growth during the forecast period. Additionally, advancements in diagnostic and treatment technologies boost the market. However, low awareness and lack of healthcare services in the middle and low-income countries are estimated to restrain the market growth during the projected period.
Biobanking Market Segmentation
The global biobanking market is segmented by products and services, sample type, storage type, application, and end-user.
equipment, services, consumables, and software. Equipment is further sub-segmented into sample transport equipment, sample processing equipment, storage equipment, sample analysis equipment, and others. Consumables are further sub-segmented into processing consumables, storage consumables, analysis consumables, collection consumables, and others. Services are sub-segmented into processing services, storage services, transport services, and supply services
biological fluids, blood products, cell lines, human tissues, nucleic acids
manual storage and automated storage. Applications of the market include life science research, regenerative medicine, and clinical research
Biobanking Market Regional Analysis
Based on region the biobanking market is segmented into Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA). The Americas region is segmented into North America and South America.
The Americas is the largest biobanking market due to heavy investments in research of theranostics and a large patient pool suffering from chronic diseases. Presence of large number of biobanks in hospitals in the U.S. can encourage growth in North America. On the other hand, South America can grow at a rapid pace due to increasing demand for advanced treatments for chronic diseases and technologically advanced diagnostic devices.
Europe can also exhibit a stellar growth rate during the forecast period due to emphasis on research and development activities in diagnosis and treatment of diseases. Collaboration between biobanks and pharmaceutical companies for encouraging research can drive the global biobanking market growth. On the other hand, APAC can be lucrative for the global biobanking market due to inclination towards drug discovery and scientific research.
Biobanking Market Competition Outlook
Tecan Trading AG, Qiagen N.V., Brooks Automation, Inc., VWR Corporation, Becton, Dickinson and Company, Promega Corporation, Hamilton Company, Panasonic Healthcare Holdings Co., Ltd., Greiner Holding AG, Thermo Fisher Scientific Inc., Chart Industries, Inc., Merck KGaA, and others are notable players of the global biobanking market.
Browse More Details at:https://www.marketresearchfuture.com/reports/biobanking-market-5967
More Healthcare Industry Related Reports
Biobanking Industry News
The Manchester Cancer Research Center biobank collects ovarian cysts samples from women afflicted with the disease. This sample can be used in the testing of new drugs and its efficacy for its future commercialization.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.